Lactic acid bacterium and use thereof
AssigneeSone Farm Co., Ltd.
InventorMasanori Sugiyama
Life of this patent
Estimating the term…
Abstract
A new lactic acid bacterium of the present invention produces, as an exopolysaccharide, a neutral polysaccharide having a structure in which N-acetylglucosamines are linked with each other via α-1,6 bond, is obtained from a fig, has a hyaluronidase inhibitory, an anti-alcoholic damage activity effect, and the like, and is therefore useful in a food and drink, a medicine, a feed, a cosmetic and the like exerting an antiallergy effect, an anti-alcoholic damage effect, and the like.
Claims9
A method for preparing a composition, comprising:
- providing a Lactobacillus paracasei strain IJH-SONE68 (Accession No. NITE BP-02242) bacterium;
- and
- mixing the Lactobacillus paracasei strain IJH-SONE68 (Accession No. NITE BP-02242) bacterium with a physiologically acceptable liquid or solid pharmaceutical carrier, a food and drink, a feed, or a cosmetic to make the composition,
- wherein the Lactobacillus paracasei strain IJH-SONE68 (Accession No. NITE BP-02242) bacterium is present at a concentration of 1×106 cfu/g to 1×1012 cfu/g, 1×106 cfu/ml to 1×1012 cfu/ml, 1×106 cells/g to 1×1012 cells/g, or at least 0.001% by weight.
A method for improving or preventing allergy, comprising administering a composition to a subject in need thereof, said composition comprising a Lactobacillus paracasei strain IJH-SONE68 (Accession No. NITE BP-02242) bacterium and a physiologically acceptable liquid or solid pharmaceutical carrier, a food and drink, a feed, or a cosmetic,
- wherein the Lactobacillus paracasei strain IJH-SONE68 (Accession No. NITE BP-02242) bacterium is present at a concentration of 1×106 cfu/g to 1×1012 cfu/g, 1×106 cfu/ml to 1×1012 cfu/ml, 1×106 cells/g to 1×1012 cells/g, or at least 0.001% by weight.
A method for improving or preventing alcoholic damage, comprising administering a composition to a subject in need thereof, said composition comprising a Lactobacillus paracasei strain IJH-SONE68 (Accession No. NITE BP-02242) bacterium and a physiologically acceptable liquid or solid pharmaceutical carrier, a food and drink, a feed, or a cosmetic,
- wherein the Lactobacillus paracasei strain IJH-SONE68 (Accession No. NITE BP-02242) bacterium is present at a concentration of 1×106 cfu/g to 1×1012 cfu/g, 1×106 cfu/ml to 1×1012 cfu/ml, 1×106 cells/g to 1×1012 cells/g, or at least 0.001% by weight.
Dependencies are inferred from the claim text.